On the one hand, it is expensive to develop innovative drugs and effort put in developing new drugs should be recognized and rewarded. On the other hand, their ethics are questioned when pharmaceutical companies raise, or keep raising drug prices. Please use Daraprim price hike during 2015 as an example to discuss business ethical decision making in your discussion.

1) Identify important stakeholders in the case of Daraprim price going up.

2) Thinking as a CEO, use one of the following ethical perspectives to evaluate whether raising drug price significantly is an ethical business decision or not: A. virtues; B. deontological; C. utilitarianism.

3) FOR and AGAINST Corporate Social Responsibilities (CSR). Please pick 2 arguments from EACH side (so you should have 4 arguments in total) and apply them to the Daraprim price hike example.

4) On what ground can government regulate drug price (please include your research when you respond to this question)? Do you support more regulation in this field and why? [You need to do a bit research on this question and. Make sure to acknowledge all the references you use.

Yes it needs to be answered